Agricultural Biotechnology: Novel Products and New Partnerships
Contents: Agricultural biotechnology: novel products and new partnerships (overview, plenary session highlights, workshop recommendations, tying it all together); workshop reports (environment and energy industry, food industry, pharmaceutical industry); keynote addresses (biotechnology: catalyst for change in agriculture, novel crops and other transgenics: how green are they?); plenary lectures; and list of participants.
What people are saying - Write a review
We haven't found any reviews in the usual places.
AARC acetochlor Agracetus agricultural biotechnology Agricultural Biotechnology Council agricultural products antigen application benefit bioremediation biosolids biotech biotechnology industry cell culture chemical commercial companies concern conditional registrations consumers contaminated Cook College cost crops disease economic environment environmental ethical ethylene ethylene-regulated tomatoes expression farm farmers fiber food industry food products fruit gene encoding gene transfer genetically engineered germplasm global groups growers harvest herbicide human impact increased institutions intellectual property issues LT-B market opportunities materials mice NABC NABC Report National Agricultural Biotechnology Norwalk virus novel products Ontario organisms paclitaxel participants partnerships patents percent pesticide pharmaceutical industry Phytoremediation plant cell culture potential PPL Therapeutics product development products and processes protein recombinant regulation regulatory risks Rutgers University sector seed social specific structural TAXOL therapeutic tomatoes traits transgenic animals transgenic plants trust utility patent vaccine vision workshop
Page 113 - Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis158 (1988) 372-377 11.
Page 18 - Trusting is rational, then, in the absence of any reason to suspect in the trusted strong and operative motives that conflict with the demands of trustworthiness as the truster sees them.
Page 114 - Estes MK. 1992. Expression, self-assembly and antigenicity of the Norwalk virus capsid protein.
Page 144 - Points to Consider in the Manufacture and Testing of Therapeutic Products for Human Use Derived from Transgenic Animals...
Page 144 - Endoproteolytic Processing of the Dibasic Cleavage Site in the Human Protein C Precursor in Transfected Mammalian Cells: Effects of Sequence Alterations on Efficiency of Cleavage. Biochemistry...
Page 98 - ... emergency action taken Local advisory board established Public encouraged to tour plant Mandatory drug testing No problems for five years Hold regular public hearings Employees carefully trained Conduct emergency training Community has access to records Serious accident is controlled Nearby health is good Monitor radioactive emissions Employees informed of problems Neighbors notified of problems No evidence of withholding information | Contribute to local charities Employees closely supervised...
Page 98 - Local board authority to close plant Evacuation plan exists On-site government inspector Rewarded for finding problems Responsive to any sign of problems Effective emergency action taken Local advisory board established Public encouraged to tour plant Mandatory drug testing No problems for five years Hold regular public hearings Employees carefully trained Conduct emergency training Community has access to records Serious accident is controlled...
Page 113 - J. (1990). Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet i, 270-273.